News

Exporting unlicensed controlled medicines from the UK involves overlapping MHRA, Home Office and overseas rules with no clear single pathway.

a no holds barred interview with the CTA and GCS

MCCS Publishes New Standardised Dosing Guide

The UK Government has announced a major shift in the way regulators operate, placing economic growth at the centre of their responsibilities.

Reflecting on Seven Years of Medical Cannabis in the UK

Inside the CTA’s Sector Strategy Committee

The Windsor Framework introduces significant updates to the regulation, packaging, and labelling of medicinal products in the UK

Cannabis based products for medicinal use in humans (CBPMs)

During the second reading, the Bill was talked out of time

​In November 2020 the Advisory Council on the Misuse of Drugs (ACMD) published an assessment of the impact of rescheduling CBPMs